The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes
Thomas NJ, Walkey HC, Kaur A, et al.
Diabetologia. Pub. online 10 Nov 2022.
Leggi
Breaking news
Atrial fibrillation and dapagliflozin efficacy in patients with preserved or mildly reduced ejection fraction
Butt JH, Kondo T, Jhund PS, et al.
J Am Coll Cardiol. 2022;80(18):1705–1717.
Leggi
The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
Khunti K, Aroda VR, Aschner P, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00278-9.
Leggi
An assessment of clinical continuous glucose monitoring targets for older and high-risk people living with type 1 diabetes
O’Neal DN, Cohen O, Vogrin S, et al.
Diabetes Technol Ther. Pub. online 31 Oct 2022
Leggi
Mediating effect of vascular risk factors underlying the link between gestational diabetes and cardiovascular disease
Retnakaran R, Shah BR
BMC Med. 2022;20(1):389.
Leggi
Improved effectiveness of immediate continuous glucose monitoring in hypoglycemia-prone people with type 1 diabetes compared with hypoglycemia-focused psycho-education following a previous structured education: a randomised controlled trial
Serné E, van den Berg IK, Racca C, et al.
Diabetes Technol Ther. Pub. online 3 Nov 2022
Leggi
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Urva S, Coskun T, Loh MT, et al.
The Lancet. Pub. online 27 Oct 2022.
Leggi
Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation Consortium: the CIT-08 study
Rickels MR, Eggerman TL, Bayman L, et al.
Diabetes Care. 2022;dc212688
Leggi
Relationship between daytime vs nighttime continuous glucose monitoring metrics with A1C in Adults with Type 1 Diabetes
Shah NV, Akturk HK, Vigers T, et al.
Diabetes Technol Ther. Pub. online 28 Oct 2022.
Leggi
Efficacy of metformin therapy in patients with cancer: a meta-analysis of 22 randomised controlled trials
Wen J, Yi Z, Chen Y et, al.
BMC Med. 2022;20(1):402.
Leggi